Skip to contentClarengateINTELLIGENCE
Companies/09289469

Stent Tek Limited

Other professional, scientific and technical activities n.e.c. · London

ActiveUnited KingdomIncorporated 2014Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-03-31

IXBRL · 141 source facts · 24 selected values

Validation findings
XBRL valid
Reporting period
2024-04-01 to 2025-03-31
Extraction status
complete
Numeric facts
70
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2025-01-01.xsd
Currency
GBP
Source identifier
Prod224_2512_09289469_20250331
Source archive
Accounts_Monthly_Data-December2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-03-31

IXBRL · 160 source facts · 12 selected values

Not assessed
legacy record
Reporting period
2023-04-01 to 2024-03-31
Extraction status
Legacy / not assessed
Numeric facts
92
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2024-01-01.xsd
Currency
GBP
Source identifier
Prod224_3200_09289469_20240331
Source archive
Accounts_Monthly_Data-December2024.zip

Accounts to 2023-03-31

IXBRL · 168 source facts · 12 selected values

Not assessed
legacy record
Reporting period
2022-11-01 to 2023-03-31
Extraction status
Legacy / not assessed
Numeric facts
99
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_1866_09289469_20230331
Source archive
Accounts_Monthly_Data-March2024.zip

Accounts to 2022-10-31

IXBRL · 189 source facts · 25 selected values

Not assessed
legacy record
Reporting period
2021-11-01 to 2022-10-31
Extraction status
Legacy / not assessed
Numeric facts
118
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0018_09289469_20221031
Source archive
Accounts_Monthly_Data-June2023.zip

Accounts to 2021-10-31

IXBRL · 191 source facts · 25 selected values

Not assessed
legacy record
Reporting period
2020-11-01 to 2021-10-31
Extraction status
Legacy / not assessed
Numeric facts
118
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0108_09289469_20211031
Source archive
Accounts_Monthly_Data-July2022.zip

Accounts to 2020-10-31

IXBRL · 167 source facts · 21 selected values

Not assessed
legacy record
Reporting period
2019-11-01 to 2020-10-31
Extraction status
Legacy / not assessed
Numeric facts
105
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0089_09289469_20201031
Source archive
Accounts_Monthly_Data-April2021.zip

Accounts to 2019-10-31

IXBRL · 150 source facts · 17 selected values

Not assessed
legacy record
Reporting period
2018-11-01 to 2019-10-31
Extraction status
Legacy / not assessed
Numeric facts
89
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0074_09289469_20191031
Source archive
Accounts_Monthly_Data-January2020.zip

Accounts to 2018-10-31

IXBRL · 110 source facts · 16 selected values

Not assessed
legacy record
Reporting period
2017-11-01 to 2018-10-31
Extraction status
Legacy / not assessed
Numeric facts
55
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0068_09289469_20181031
Source archive
Accounts_Monthly_Data-July2019.zip

Accounts to 2016-10-31

IXBRL · 70 source facts · 14 selected values

Not assessed
legacy record
Reporting period
2015-11-01 to 2016-10-31
Extraction status
Legacy / not assessed
Numeric facts
24
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0044_09289469_20161031
Source archive
Accounts_Monthly_Data-July2017.zip

Accounts to 2015-10-31

IXBRL · 57 source facts · 7 selected values

Not assessed
legacy record
Reporting period
2014-10-31 to 2015-10-31
Extraction status
Legacy / not assessed
Numeric facts
13
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0032_09289469_20151031
Source archive
Accounts_Monthly_Data-July2016.zip

Registered details

09289469
Status
Active
Type
Private Limited Company
Incorporated
2014-10-31
Jurisdiction
—
Registered office
UNIT 12 BALTIMORE HOUSE, JUNIPER DRIVE, LONDON, SW18 1TS, ENGLAND

Classification

1 SIC codes
74909

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

6 matched grants
Regenerative Endovascular AV Fistula Creation (rePATH)LeadLive
Innovate UK · EU-Funded · 2024-12-01 – 2027-10-31
£306,676
awarded
Regenerative Endovascular AV Fistula Creation (rePATH)LeadActive
EU · EU-Funded · 2024-12-01 – 2027-05-30
£306,676
whole project
Regenerative Endovascular AV Fistula Creation (rePATH)Active
EU · EU-Funded · 2024-12-01 – 2027-05-30
£306,676
whole project
Improving outcomes for haemodialysis patients through minimally invasive arteriovenous fistula creationLead
Innovate UK · Collaborative R&D · 2023-05-01 – 2025-02-28 · with 1 other participant
£672,480
awarded
Stent Tek Limitedlead£672,480
Stent Tek Limited: Improving outcomes for hemodialysis patients through minimally invasive vascular access creation.Lead
Innovate UK · GRD Proof of Concept · 2015-11-01 – 2016-10-31
£99,693
awarded
IP Support for Stent Tek Ltd.Lead
Innovate UK · Vouchers · 2015-02-01 – 2015-07-31
£5,000
awarded